KalVista Pharmaceuticals, Inc. ($KALV)
Filing Information
| Accession Number | 0001827505-26-000002 |
|---|---|
| Form Type | 4 |
| Filing Date | Feb 25, 2026 |
| Document | View SEC Filing |
Transactions
5
Total Shares
26,475
Total Value
$61,878.03
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Commercial Officer | Common Stock | โ | Feb 21, 2026 | Exercise/Conversion | 6,250 | โ | โ | 45,978 | Direct | โ | View Details | |
Chief Commercial Officer | Common Stock | โ | Feb 22, 2026 | Exercise/Conversion | 5,000 | โ | โ | 50,978 | Direct | โ | View Details | |
Chief Commercial Officer | Common Stock | โ | Feb 23, 2026 | Sale | 3,975 | $15.57 | $61,878.03 | 47,003 | Direct | โ | View Details | |
Chief Commercial Officer | Restricted Stock Unit | Derivative | Feb 21, 2026 | Exercise/Conversion | 6,250 | $0.00 | $0.00 | 75,000 | Direct | โ | View Details | |
Chief Commercial Officer | Restricted Stock Unit | Derivative | Feb 22, 2026 | Exercise/Conversion | 5,000 | $0.00 | $0.00 | 45,000 | Direct | โ | View Details |